William Blair & Company
ELV icon

William Blair & Company’s Elevance Health ELV Stock Holding History

William Blair & Company’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.25M Sell
4,273
-756
-15% -$248K ﹤0.01% 873
2025
Q4 		$1.76M Sell
5,029
-1,158
-19% -$391K ﹤0.01% 780
2025
Q3 		$2M Sell
6,187
-73
-1% -$22.7K 0.01% 728
2025
Q2 		$2.43M Buy
6,260
+180
+3% +$72.4K 0.01% 672
2025
Q1 		$2.64M Sell
6,080
-976
-14% -$392K 0.01% 652
2024
Q4 		$2.6M Sell
7,056
-8,580
-55% -$3.59M 0.01% 660
2024
Q3 		$8.13M Buy
15,636
+880
+6% +$470K 0.02% 387
2024
Q2 		$8M Buy
14,756
+2,622
+22% +$1.39M 0.02% 371
2024
Q1 		$6.29M Buy
12,134
+6,610
+120% +$3.29M 0.02% 427
2023
Q4 		$2.61M Sell
5,524
-852
-13% -$394K 0.01% 617
2023
Q3 		$2.78M Sell
6,376
-412
-6% -$187K 0.01% 583
2023
Q2 		$3.02M Buy
6,788
+1,251
+23% +$577K 0.01% 568
2023
Q1 		$2.94M Buy
5,537
+448
+9% +$213K 0.01% 569
2022
Q4 		$2.61M Buy
5,089
+396
+8% +$201K 0.01% 566
2022
Q3 		$2.22M Buy
4,693
+295
+7% +$141K 0.01% 592
2022
Q2 		$2.12M Sell
4,398
-218
-5% -$108K 0.01% 622
2022
Q1 		$2.27M Sell
4,616
-79
-2% -$36.1K 0.01% 668
2021
Q4 		$2.18M Buy
4,695
+476
+11% +$200K 0.01% 709
2021
Q3 		$1.57M Sell
4,219
-635
-13% -$241K 0.01% 765
2021
Q2 		$1.85M Buy
4,854
+126
+3% +$48.2K 0.01% 729
2021
Q1 		$1.7M Buy
4,728
+107
+2% +$34.4K 0.01% 734
2020
Q4 		$1.48M Buy
4,621
+756
+20% +$232K 0.01% 732
2020
Q3 		$1.04M Sell
3,865
-378
-9% -$102K ﹤0.01% 744
2020
Q2 		$1.12M Sell
4,243
-234
-5% -$62.4K 0.01% 696
2020
Q1 		$1.02M Sell
4,477
-162
-3% -$44.1K 0.01% 658
2019
Q4 		$1.4M Buy
4,639
+230
+5% +$63.3K 0.01% 693
2019
Q3 		$1.06M Sell
4,409
-377
-8% -$103K 0.01% 732
2019
Q2 		$1.35M Buy
4,786
+2,170
+83% +$593K 0.01% 682
2019
Q1 		$751K Buy
2,616
+485
+23% +$140K ﹤0.01% 822
2018
Q4 		$560K Buy
2,131
+31
+1% +$8.52K ﹤0.01% 868
2018
Q3 		$576K Buy
2,100
+295
+16% +$76.6K ﹤0.01% 916
2018
Q2 		$430K Sell
1,805
-326
-15% -$75.5K ﹤0.01% 991
2018
Q1 		$468K Sell
2,131
-1,730
-45% -$406K ﹤0.01% 941
2017
Q4 		$869K Buy
3,861
+469
+14% +$99.9K 0.01% 780
2017
Q3 		$644K Sell
3,392
-153
-4% -$29.1K ﹤0.01% 849
2017
Q2 		$667K Buy
3,545
+960
+37% +$172K 0.01% 876
2017
Q1 		$426K Buy
2,585
+80
+3% +$12.7K ﹤0.01% 950
2016
Q4 		$360K Hold
2,505
– – ﹤0.01% 936
2016
Q3 		$314K Buy
+2,505
New +$323K ﹤0.01% 1005
2016
Q2 		– Sell
-10,452
Closed -$1.45M – 1244
2016
Q1 		$1.45M Buy
10,452
+610
+6% +$81.5K 0.01% 526
2015
Q4 		$1.37M Buy
9,842
+1,403
+17% +$193K 0.01% 551
2015
Q3 		$1.18M Buy
8,439
+1,219
+17% +$183K 0.01% 704
2015
Q2 		$1.19M Sell
7,220
-1,275
-15% -$204K ﹤0.01% 1541
2015
Q1 		$1.31M Sell
8,495
-1,742
-17% -$248K ﹤0.01% 1473
2014
Q4 		$1.29M Buy
10,237
+3,775
+58% +$466K ﹤0.01% 1404
2014
Q3 		$772K Buy
6,462
+181
+3% +$20.8K ﹤0.01% 1556
2014
Q2 		$675K Buy
6,281
+1,100
+21% +$113K ﹤0.01% 1576
2014
Q1 		$515K Sell
5,181
-300
-5% -$27.1K ﹤0.01% 1611
2013
Q4 		$506K Buy
5,481
+2,600
+90% +$231K ﹤0.01% 1591
2013
Q3 		$240K Sell
2,881
-235
-8% -$20.1K ﹤0.01% 1818
2013
Q2 		$255K Buy
+3,116
New +$233K ﹤0.01% 1731

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

William Blair & Company's ELV Position: Q1 2026 in Review

William Blair & Company reduced its Elevance Health (ELV) stake by 15% in Q1 2026, selling an estimated $248K and leaving 4,273 shares worth $1.25M. The position accounts for ﹤0.01% of the portfolio, ranked #873.

William Blair & Company first reported a position in ELV in Q2 2013 and has held it in 51 quarters since. The position peaked at $8.13M in Q3 2024. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • William Blair & Company held 4,273 shares of Elevance Health worth $1.25M as of Q1 2026.
  • William Blair & Company sold 756 Elevance Health shares in Q1 2026, an estimated $248K.
  • Elevance Health made up ﹤0.01% of William Blair & Company's portfolio in Q1 2026, its #873 holding.
  • William Blair & Company first reported a position in Elevance Health in Q2 2013 and has held it in 51 quarters since.
  • William Blair & Company's Elevance Health position peaked at $8.13M in Q3 2024.
  • 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on William Blair & Company's 13F filing for Q1 2026, filed 8 May 2026.